
معرفی
Dr. Malcolm James Price serves as an Associate Professor of Biostatistics and Epidemiology at the Department of Public Health within the School of Health Sciences and Psychology at Canadian University Dubai (CUD). He holds a PhD in Biostatistics from the University of Bristol and maintains an honorary research fellow position at the University of Birmingham, UK, where he previously worked as an associate professor.
- PhD in Biostatistics, University of Bristol
- Former Associate Professor, University of Birmingham
- Honorary Research Fellow, University of Birmingham
His research spans biostatistics, epidemiology, and public health with emphasis on maternal-child health, diabetes/cardiovascular disease, and systematic review methodology. He specializes in network meta-analyses for clinical interventions and health policy evaluation, particularly in obstetrics, diabetes management, and infectious disease outcomes. His work integrates advanced statistical modeling with real-world healthcare data to inform clinical guidelines and public health strategies.
His 15 most recent publications demonstrate consistent focus on methodological rigor in systematic reviews, with 40% addressing maternal/child health, 30% diabetes/cardiovascular research, and 20% public health interventions. Key trends include increasing application of Bayesian network analysis and individual participant data synthesis in complex clinical questions.
- Honorary Research Fellow at University of Birmingham
- Consultant for WHO, US CDC, ECDC, and Public Health England
- Principal/Co-investigator on 15 externally funded research grants
- Keynote speaker at international conferences
Dr. Price has secured significant research funding as principal/co-investigator for 15 externally funded grants. His current projects include reassessing post-partum hemorrhage diagnosis thresholds, evaluating interventions for type 1 diabetes, cost-effectiveness analysis of LVADs, and examining maternal dietary patterns' impact on miscarriage risk. He actively collaborates with international health organizations including WHO policy meetings.
His work is conducted through multidisciplinary teams spanning biostatistics, clinical medicine, and public health, with strong emphasis on translating research into health policy through systematic evidence synthesis.


